Suppr超能文献

具有结节状磨玻璃影的肺癌中的表皮生长因子受体突变和间变性淋巴瘤激酶重排

Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.

作者信息

Ko Sung-Jun, Lee Yeon Joo, Park Jong Sun, Cho Young-Jae, Yoon Ho Il, Chung Jin-Haeng, Kim Tae Jung, Lee Kyung Won, Kim Kwhanmien, Jheon Sanghoon, Kim Hyojin, Lee Jae Ho, Lee Choon-Taek

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

BMC Cancer. 2014 May 3;14:312. doi: 10.1186/1471-2407-14-312.

Abstract

BACKGROUND

Nodular ground-glass opacities (nGGO) are a specific type of lung adenocarcinoma. ALK rearrangements and driver mutations such as EGFR and K-ras are frequently found in all types of lung adenocarcinoma. EGFR mutations play a role in the early carcinogenesis of nGGOs, but the role of ALK rearrangement remains unknown.

METHODS

We studied 217 nGGOs resected from 215 lung cancer patients. Pathology, tumor size, tumor disappearance rate, and the EGFR and ALK markers were analyzed.

RESULTS

All but one of the resected nGGOs were adenocarcinomas. ALK rearrangements and EGFR mutations were found in 6 (2.8%) and 119 (54.8%) cases. The frequency of ALK rearrangement in nGGO was significantly lower than previously reported in adenocarcinoma. Advanced disease stage (p = 0.018) and larger tumor size (p = 0.037) were more frequent in the ALK rearrangement-positive group than in ALK rearrangement-negative patients. nGGOs with ALK rearrangements were associated with significantly higher pathologic stage and larger maximal and solid diameter in comparison to EGFR-mutated lesions.

CONCLUSION

ALK rearrangement is rare in lung cancer with nGGOs, but is associated with advanced stage and larger tumor size, suggesting its association with aggressive progression of lung adenocarcinoma. ALK rearrangement may not be important in early pathogenesis of nGGO.

摘要

背景

结节状磨玻璃影(nGGO)是肺腺癌的一种特殊类型。在所有类型的肺腺癌中,ALK重排以及诸如EGFR和K-ras等驱动基因突变都很常见。EGFR突变在nGGO的早期致癌过程中发挥作用,但ALK重排的作用尚不清楚。

方法

我们研究了从215例肺癌患者中切除的217个nGGO。分析了病理、肿瘤大小、肿瘤消失率以及EGFR和ALK标志物。

结果

除1例切除的nGGO外,其余均为腺癌。在6例(2.8%)和119例(54.8%)病例中发现了ALK重排和EGFR突变。nGGO中ALK重排的频率显著低于先前报道的腺癌。ALK重排阳性组的疾病晚期(p = 0.018)和肿瘤较大(p = 0.037)的情况比ALK重排阴性患者更常见。与EGFR突变的病变相比,伴有ALK重排的nGGO与显著更高的病理分期以及更大的最大直径和实性直径相关。

结论

ALK重排在伴有nGGO的肺癌中罕见,但与晚期和更大的肿瘤大小相关,提示其与肺腺癌的侵袭性进展有关。ALK重排在nGGO的早期发病机制中可能并不重要。

相似文献

2
Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.
Eur Radiol. 2015 May;25(5):1257-66. doi: 10.1007/s00330-014-3516-z. Epub 2015 Jan 11.
3
Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
Eur J Radiol. 2016 Nov;85(11):1934-1940. doi: 10.1016/j.ejrad.2016.08.023. Epub 2016 Aug 30.
4
Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
Lung Cancer. 2014 Nov;86(2):190-4. doi: 10.1016/j.lungcan.2014.09.007. Epub 2014 Sep 17.
5
Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
PLoS One. 2015 Sep 30;10(9):e0139264. doi: 10.1371/journal.pone.0139264. eCollection 2015.
6
Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.
J Cancer Res Clin Oncol. 2014 Mar;140(3):453-60. doi: 10.1007/s00432-014-1584-8. Epub 2014 Jan 18.
7
Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
PLoS One. 2016 Aug 12;11(8):e0161081. doi: 10.1371/journal.pone.0161081. eCollection 2016.
10
Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.
Mod Pathol. 2013 Nov;26(11):1468-77. doi: 10.1038/modpathol.2013.95. Epub 2013 Jun 7.

引用本文的文献

3
Molecular Alterations in Lung Adenocarcinoma With Ground-Glass Nodules: A Systematic Review and Meta-Analysis.
Front Oncol. 2021 Sep 13;11:724692. doi: 10.3389/fonc.2021.724692. eCollection 2021.
5
[Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of and minimally invasive lung adenocarcinomas].
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Sep 30;39(9):1107-1112. doi: 10.12122/j.issn.1673-4254.2019.09.17.
7
Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology.
Transl Lung Cancer Res. 2017 Feb;6(1):68-75. doi: 10.21037/tlcr.2017.01.02.
9
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
Medicine (Baltimore). 2015 Oct;94(41):e1753. doi: 10.1097/MD.0000000000001753.

本文引用的文献

3
Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.
Respir Med. 2014 Feb;108(2):388-94. doi: 10.1016/j.rmed.2013.11.020. Epub 2013 Dec 10.
5
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
N Engl J Med. 2013 Jun 20;368(25):2385-94. doi: 10.1056/NEJMoa1214886. Epub 2013 Jun 1.
7
Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients.
J Thorac Oncol. 2013 Jun;8(6):766-72. doi: 10.1097/JTO.0b013e31828b5228.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验